A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4184 (2006.01) A61K 31/4418 (2006.01) A61K 31/4439 (2006.01) C07D 235/12 (2006.01) C07D 235/18 (2006.01) C07D 401/06 (2006.01) C07D 403/08 (2006.01) C07D 403/12 (2006.01) C07D 405/12 (2006.01) C07D 409/12 (2006.01) C07D 413/12 (2006.01)
Patent
CA 2389259
Novel benzimidazoles, substituted in the 2-position by substituted benzyl groups or heteroaryl groups are effective as NMDA NR2B antagonists and are useful for relieving pain.
De nouveaux benzimidazoles, substitués dans la position 2 par des groupes benzyle ou des groupes hétéroaryle substitués, sont efficaces en tant qu'antagonistes de NMDA et NR2B, et sont utiles pour soulager la douleur.
Claiborne Christopher F.
Claremon David A.
Liverton Nigel J.
Mccauley John A.
Theberge Cory R.
Merck & Co. Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
2-benzyl and 2-heteroaryl benzimidazole nmda/nr2b antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2-benzyl and 2-heteroaryl benzimidazole nmda/nr2b antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-benzyl and 2-heteroaryl benzimidazole nmda/nr2b antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1460345